<article>Hong Kong-based private equity firm <a href="https://www.dealstreetasia.com/?s=Dignari%20Capital Partners">Dignari Capital Partners</a> (DCP) has closed its second fund &#8211; <a href="https://www.dealstreetasia.com/?s=DCP%20China Credit Fund II">DCP China Credit Fund II</a> &#8211; after receiving $626 million in commitments, according to its filing with the SEC.
The second fund, launched in January 2018, exceeded the target of $500 million and has attracted commitments from 13 investors, according to the filing signed by its founder Grace Tan, formerly with HSBC and Asia Debt Management.</article>

Hong Kong-based private equity firm <a href="https://www.dealstreetasia.com/?s=Dignari%20Capital Partners">Dignari Capital Partners</a> (DCP) has closed its second fund &#8211; <a href="https://www.dealstreetasia.com/?s=DCP%20China Credit Fund II">DCP China Credit Fund II</a> &#8211; after receiving $626 million in commitments, according to its filing with the SEC.
The second fund, launched in January 2018, exceeded the target of $500 million and has attracted commitments from 13 investors, according to the filing signed by its founder Grace Tan, formerly with HSBC and Asia Debt Management.
The close of DCP China Credit Fund II comes nearly five years after Dignari raised $256.2 million for its first fund in 2014, the DCP China Credit Fund I. The funds are a continuation of the team&#8217;s prior work in the Greater China space, the firm said on its website.
The second fund had a minimum investment cheque size of $10 million.
The firm invests in distressed assets, pre-IPO financing, platform acquisition, corporate restructuring, outbound direct investment, privatisation and re-listing, mezzanine lending and convertible and high yield bonds.
It typically invests between $50 million and $75 million and targets around 10 deals from its two funds.
Founded in 2014 by Grace Tan, who was formerly with HSBC and Asia Debt Management Hong Kong, the team has over a decade in experience investing in sectors of chemicals, oil and gas, retail, utilities, F&amp;B, transportation, and professional services in China.
“Going forward, we look forward to developing and adapting our business so we may continue to capture opportunities in China&#8217;s ever-changing financial markets,” the firm said.
In 2016, Dignari Capital was said to participate in the $1.2-billion buyout deal of Wharf T&amp;T led by MBK Partners and TPG Capital, through a $103.5 million mezzanine debt along with Chinese financial services firm Huatai Securities.
A year later, the private credit fund manager purchased HK$280 million ($35.7 million) convertible notes of Jacobson Pharma, a Hong Kong-listed generic drugs and proprietary medicines company.
Also Read:
<a style="color: #ff0000;" href="https://www.dealstreetasia.com/stories/hk-based-dignari-capital-raises-477m-for-second-china-private-credit-fund-116896/">HK-based Dignari Capital raises $477m for second China private credit fund</a>

Hong Kong-based private equity firm Dignari Capital Partners (DCP) has closed its second fund - DCP China Credit Fund II - with $626 million in commitments.

HK's Dignari Capital Partners closes second China private credit fund at $626m

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

HK's Dignari Capital Partners closes second China private credit fund at $626m

Create an account to continue reading this premium story for free

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief